Clinical Trial Update: The Role of Erythropoietin in Myelodysplastic Syndrome

View source ↗

Summary

An update on a clinical trial examining erythropoietin as a treatment for myelodysplastic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University of Utah | Conditions: Myelodysplastic Syndrome | Status: COMPLETED